ArticleFrontiers in health services2025
A window of opportunity: a pilot study exploring smoking cessation support during COPD hospitalisation.
Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The right time to quit: patients' experiences of smoking cessation support during COPD hospitalisation.Health psychology and behavioral medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A significant proportion of patients with chronic obstructive pulmonary disease (COPD) continue smoking after diagnosis, contributing to increased symptom burden, more frequent exacerbations and poorer long-term outcomes. Hospitalisation due to COPD exacerbation may serve as a "window of opportunity" for delivering smoking cessation support. Aim: This pilot study evaluated the feasibility of integrating structured smoking cessation support into routine inpatient care for patients hospitalised with a COPD exacerbation. Methods: We followed 45 patients admitted for COPD exacerbation who reported active smoking at baseline. Smoking status and COPD symptoms (COPD Assessment Test, CAT) were evaluated at baseline, 1 month and 3 months after discharge. Comparisons were made between participants with smoking and non-smoking status at 1 month follow-up, and across three groups at 3 months: sustained non-smoking, sustained smoking and smoking relapse. Results: At 1 month, 30 patients (66.7%) reported abstinence, and 19 (42.2%) remained abstinent at 3 months. Improvements in mean CAT scores were observed over time, from 22.9 (95% CI = 20.0-25.7) at baseline to 13.9 (CI = 11.4-16.3) at 1 month and 12.9 (CI = 10.1-15.6) at 3 months. A trend towards lower CAT scores were observed for participants with non-smoking status at follow-up, compared with those who were smoking. We observed, that those who sustained non-smoking at follow-up were older, had higher baseline expectations of quitting and reported greater confidence in their ability to stop. However, those who relapsed at three months were the oldest. Being without a partner appeared more common among sustained smoking at follow-up. Conclusion: Smoking cessation support initiated during COPD hospitalisation was feasible and the majority of patients reported short-term abstinence and meaningful reductions in symptom burden. Age, expectations and confidence appeared to affect cessation trajectories, but should be explored further in larger, controlled trials and implementation setups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.